Rethinking the benefits of digital adherence technologies for tuberculosis treatment

Lancet. 2025 Apr 5;405(10485):1122-1123. doi: 10.1016/S0140-6736(25)00199-0. Epub 2025 Mar 11.

Authors

Florian M Marx¹, Abdulkadir Civan²

Affiliations

¹ Department of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, 69120 Heidelberg, Germany; South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa. Electronic address: florian.marx@uni-heidelberg.de.
² Department of Infectious Disease and Tropical Medicine, Heidelberg University Hospital, 69120 Heidelberg, Germany.

PMID: 40086456
DOI: 10.1016/S0140-6736(25)00199-0

No abstract available

Publication types

Comment